References
- Parlog A, Schluter D, Dunay IR. Toxoplasma gondii-induced neuronal alterations. Parasite Immunol 2015; 37: 159-170. https://doi.org/10.1111/pim.12157
- Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30: 1217-1258. https://doi.org/10.1016/S0020-7519(00)00124-7
- Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg 2014; 90: 794-799. https://doi.org/10.4269/ajtmh.13-0722
- Goldstein EJC, Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008; 47: 554-566. https://doi.org/10.1086/590149
- Liu Q, Singla LD, Zhou H. Vaccines against Toxoplasma gondii: status, challenges and future directions. Hum Vaccin Immunother 2012; 8: 1305-1308. https://doi.org/10.4161/hv.21006
- Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, He XH, Zhou DH, He Y, Li HX, Liao M, Zhu XQ. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 2011; 29: 6614-6619. https://doi.org/10.1016/j.vaccine.2011.06.110
- Kang SM, Song JM, Quan FS, Compans RW. Influenza vaccines based on virus-like particles. Virus Res 2009; 143: 140-146. https://doi.org/10.1016/j.virusres.2009.04.005
- Lee DH, Lee SH, Kim AR, Quan FS. Virus-like nanoparticle vaccine confers protection against Toxoplasma gondii. PLoS One 2016; 11: e0161231. https://doi.org/10.1371/journal.pone.0161231
- Lee SH, Kim AR, Lee DH, Rubino I, Choi HJ, Quan FS. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection. PLoS One 2017; 12: e0175644. https://doi.org/10.1371/journal.pone.0175644
- Lee SH, Kang HJ, Lee DH, Kang SM, Quan FS. Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection. Vaccine 2018; 36: 5692-5700. https://doi.org/10.1016/j.vaccine.2018.08.016
- Lee SH, Lee DH, Piao Y, Moon EK, Quan FS. Influenza M1 viruslike particles consisting of Toxoplasma gondii rhoptry protein 4. Korean J Parasitol 2017; 55: 143-148. https://doi.org/10.3347/kjp.2017.55.2.143
- Joyce BR, Queener SF, Wek RC, Sullivan WJ Jr. Phosphorylation of eukaryotic initiation factor-2{alpha} promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii. Proc Natl Acad Sci USA 2010; 107: 17200-17205. https://doi.org/10.1073/pnas.1007610107
- Wang PY, Yuan ZG, Petersen E, Li J, Zhang XX, Li XZ, Li HX, Lv ZC, Cheng T, Ren D, Yang GL, Lin RQ, Zhu XQ. Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol 2012; 19: 1916-1920. https://doi.org/10.1128/CVI.00397-12
- Fang R, Feng H, Nie H, Wang L, Tu P, Song Q, Zhou Y, Zhao J. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine 2010; 28: 1803-1807. https://doi.org/10.1016/j.vaccine.2009.12.005
- Choi HJ, Yoo DG, Bondy BJ, Quan FS, Compans RW, Kang SM, Prausnitz MR. Stability of influenza vaccine coated onto microneedles. Biomaterials 2012; 33: 3756-3769. https://doi.org/10.1016/j.biomaterials.2012.01.054
- Wek RC, Cavener DR. Translational control and the unfolded protein response. Antioxid Redox Signal 2007; 9: 2357-2371. https://doi.org/10.1089/ars.2007.1764
- Fentress SJ, Sibley LD. The secreted kinase ROP18 defends Toxoplasma's border. Bioessays 2011; 33: 693-700. https://doi.org/10.1002/bies.201100054
- Dorfmeier CL, Shen S, Tzvetkov EP, McGettigan JP. Reinvestigating the role of IgM in rabies virus postexposure vaccination. J Virol 2013; 87: 9217-9222. https://doi.org/10.1128/JVI.00995-13
- Racine R, Winslow GM. IgM in microbial infections: taken for granted? Immunol Lett 2009; 125: 79-85. https://doi.org/10.1016/j.imlet.2009.06.003
- Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009; 83: 5726-5734. https://doi.org/10.1128/JVI.00207-09
Cited by
- Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice vol.57, pp.2, 2018, https://doi.org/10.3347/kjp.2019.57.2.93
- Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection vol.11, pp.7, 2018, https://doi.org/10.3390/pharmaceutics11070342
- Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses vol.14, pp.8, 2019, https://doi.org/10.1371/journal.pone.0220865
- Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations vol.12, pp.10, 2018, https://doi.org/10.3390/pharmaceutics12100989
- Protective immunity induced by CpG ODN‐adjuvanted virus‐like particles containing Toxoplasma gondii proteins vol.43, pp.1, 2018, https://doi.org/10.1111/pim.12799